Digest Network Come funziona
Network
/
Società
Se
Non verificato

Seismic Therapeutic, Inc.

Di cosa scriviamo

BiotecnologiaEventiFarmaceuticaIndustriaSalute

15 comunicati stampa

Guarda tutti i comunicati
02/06/2025
Seismic Therapeutic Appoints Sophie Jones, M.D., as Chief Financial Officer
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0
10/04/2025
Industria
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S-4321, a Novel Bifunctional Antibody that Agonizes PD-1 and FcγRIIb Inhibitory Receptors for the Treatment of Autoimmune Disease
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0
18/03/2025
Mercato del lavoro
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Seismic Therapeutic Forms Translational Medicine Advisory Board with Prominent Experts in Immunology, Rheumatology, Dermatology and Neurology
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0
11/03/2025
Industria
Tecnica
Scienza
Medicina - Varie
Biotecnologia
Salute
Farmaceutica
Seismic Therapeutic Doses First Cohort in Phase 1 Clinical Trial of S‑1117, a Novel Pan‑IgG Protease Therapy for Antibody-Mediated Diseases
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0
28/02/2025
Salute
Medicina - Varie
Scienza
Farmaceutica
Biotecnologia
Eventi
Fiere
Industria
Seismic Therapeutic Presents Preclinical Data on S-8484, Its Novel IgE Protease, for Treatment of Allergic Diseases
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0
09/12/2024
Eventi
Industria
Biotecnologia
Farmaceutica
Salute
Medicina - Varie
Seismic Therapeutic Presents New Preclinical Efficacy Data for S-1117 in Prophylactic and Therapeutic Animal Models of Immune Thrombocytopenia (ITP) at 66th ASH Annual Meeting
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0
18/11/2024
Biotecnologia
Salute
Farmaceutica
Medicina - Varie
Eventi
Industria
Seismic Therapeutic Presents New Preclinical Data for S-4321, a Next Generation PD‑1:FcγRIIb-Selective Bifunctional Agonist Antibody for the Treatment of Autoimmune Disease, at ACR Convergence 2024
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0
07/11/2024
Eventi
Fiere
Biotecnologia
Farmaceutica
Salute
Seismic Therapeutic to Participate in Upcoming Investor Conferences
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0
06/11/2024
Eventi
Industria
Information Technology
Salute
Tecnica
Software
Farmaceutica
Seismic Therapeutic Presents Data Demonstrating Key Capabilities and Broad Utility of Its Machine Learning-enabled IMPACT Platform to Create Novel Biologic Medicines
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0
05/11/2024
Eventi
Fiere
Industria
Scienza
Tecnica
Biotecnologia
Medicina - Varie
Farmaceutica
Salute
Seismic Therapeutic Announces Presentations at Upcoming Scientific and Medical Conferences
Fonte
Seismic Therapeutic, Inc.
Emittente
Business Wire
1.00
0

Recapiti

Social Media

Seguaci
0
Compatibilità
0